Live From Las Vegas! Greatest Hits from Fall Clinical Dermatology 2023

Published: Oct. 26, 2023, 10 a.m.

In this episode of Derms and Conditions, Dr. Jim Del Rosso and Dr. Gary Goldenberg discuss some of the highlights from the meeting. These include recent FDA approvals such as\nbimekizumab for psoriasis and the triple topical combination for acne vulgaris, the newer\xa0 nonsteroidal topical agents, tapinarof and roflumilast, and their relevant clinical use, the\xa0\nsignificance of narrow-spectrum oral antibiotic therapy with sarecycline as compared to\xa0 other oral tetracycline with regard to antibiotic resistance, and physical devices such as\nlaser systems used to treat acne vulgaris.